Who owns HIIQ - HEALTH INS INNOVATIONS INC - COM CL A based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) Institutional Ownership

Q: What is CUSIP 42225K106?

CUSIP 42225K106 is the security identifier used in SEC filing datasets for HIIQ - HEALTH INS INNOVATIONS INC - COM CL A.

CUSIP: 42225K106

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2020

Type / Class: Equity / COM CL A
Symbol: HIIQ

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 42225K106?
CUSIP 42225K106 identifies HIIQ - HEALTH INS INNOVATIONS INC - COM CL A in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 42225K106:

Q1 2020 (0 holders) Q4 2019 (107 holders) Q3 2019 (116 holders) Q2 2019 (123 holders) Q1 2019 (139 holders) Q4 2018 (140 holders) Q3 2018 (144 holders) Q2 2018 (138 holders) Q1 2018 (127 holders) Q4 2017 (102 holders)

Institutional Holders of HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2020 Q1	0	$0	-$241,585,082	$0	$0		0
2019 Q4	13,857,599	$267,322,240	-$16,723,366	$65,945,000	$81,038,000	$19.29	107
2019 Q3	12,097,651	$301,551,395	-$50,110,305	$30,358,000	$67,477,000	$24.93	116
2019 Q2	13,976,067	$361,996,367	-$74,979,082	$33,580,000	$57,478,000	$25.92	123
2019 Q1	16,773,951	$449,881,640	-$3,287,316	$59,384,000	$80,016,000	$26.82	139
2018 Q4	16,939,006	$452,769,754	+$19,254,655	$32,911,000	$24,860,000	$26.73	140
2018 Q3	13,416,267	$825,620,482	-$32,444,221	$51,594,000	$33,765,000	$61.65	144
2018 Q2	14,584,461	$471,767,432	+$62,096,998	$15,976,000	$26,851,000	$32.35	138
2018 Q1	12,776,914	$369,282,774	-$5,550,589	$14,314,000	$9,547,000	$28.90	127
2017 Q4	13,109,369	$327,064,471	+$45,828,225	$8,471,000	$11,768,000	$24.95	102
2017 Q3	11,196,809	$162,291,634	-$6,929,480	$6,733,000	$12,463,000	$14.50	113
2017 Q2	10,575,604	$248,567,566	+$77,448,070	$1,955,000	$1,343,000	$23.50	99
2017 Q1	8,179,277	$130,866,000	+$69,626,562			$16.00	76
2016 Q4	3,973,594	$70,925,000	+$22,941,613			$17.85	44
2016 Q3	3,512,783	$18,439,000	-$2,095,559			$5.25	31
2016 Q2	4,103,120	$16,125,000	-$1,784,297			$3.93	31
2016 Q1	4,248,209	$25,949,000	-$1,931,163			$6.11	21
2015 Q4	4,555,186	$30,518,000	+$1,561,333			$6.70	23
2015 Q3	4,332,402	$21,662,000	-$1,028,133			$5.00	24
2015 Q2	4,580,861	$22,767,000	-$2,164,906			$4.97	28
2015 Q1	4,620,708	$35,956,250	-$1,571,777			$7.81	30
2014 Q4	4,857,422	$34,755,146	-$1,511,089			$7.16	35
2014 Q3	4,758,569	$51,519,881	-$4,084,563			$10.79	40
2014 Q2	5,143,292	$63,367,289	-$927,437			$12.32	35
2014 Q1	5,248,941	$54,203,525	+$8,477,842			$10.34	41